- Home
- STRO vs LOCL Comparison
STRO vs LOCL Comparison
Compare STRO & LOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- LOCL
- Stock Information
- Founded
- STRO 2003
- LOCL 2021
- Country
- STRO United States
- LOCL United States
- Employees
- STRO N/A
- LOCL N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- LOCL Farming/Seeds/Milling
- Sector
- STRO Health Care
- LOCL Consumer Staples
- Exchange
- STRO Nasdaq
- LOCL Nasdaq
- Market Cap
- STRO 68.1M
- LOCL 55.8M
- IPO Year
- STRO 2018
- LOCL N/A
- Fundamental
- Price
- STRO $0.88
- LOCL $3.33
- Analyst Decision
- STRO Hold
- LOCL
- Analyst Count
- STRO 7
- LOCL 0
- Target Price
- STRO $1.97
- LOCL N/A
- AVG Volume (30 Days)
- STRO 980.5K
- LOCL 26.4K
- Earning Date
- STRO 11-12-2025
- LOCL 11-13-2025
- Dividend Yield
- STRO N/A
- LOCL N/A
- EPS Growth
- STRO N/A
- LOCL N/A
- EPS
- STRO N/A
- LOCL N/A
- Revenue
- STRO $104,473,000.00
- LOCL $44,020,000.00
- Revenue This Year
- STRO $65.48
- LOCL $42.28
- Revenue Next Year
- STRO N/A
- LOCL $78.57
- P/E Ratio
- STRO N/A
- LOCL N/A
- Revenue Growth
- STRO N/A
- LOCL 39.74
- 52 Week Low
- STRO $0.52
- LOCL $1.18
- 52 Week High
- STRO $4.60
- LOCL $5.75
- Technical
- Relative Strength Index (RSI)
- STRO 51.76
- LOCL 59.52
- Support Level
- STRO $0.77
- LOCL $2.90
- Resistance Level
- STRO $0.89
- LOCL $4.00
- Average True Range (ATR)
- STRO 0.07
- LOCL 0.26
- MACD
- STRO -0.00
- LOCL 0.03
- Stochastic Oscillator
- STRO 50.62
- LOCL 42.79
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About LOCL Local Bounti Corporation
Local Bounti Corp is a controlled environment agriculture company. Its business model is based on building local facilities, operated by local teams, to deliver fresh and quality produce to local communities while maintaining a limited carbon footprint. Using proprietary technology to grow leafy greens and herbs in smart greenhouses with a cultivation process that uses less water and land than conventional agriculture, free from herbicides or pesticides, it delivers products that have a longer shelf life, and are good in taste.